Delivery Order SPE2DB20D1100-SPE2DB25FD9V7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $21,929.06 to AmerisourceBergen Drug Corp for the supply of TALTZ 80 MG/ML Autoinjector, with an ultimate completion date of July 25, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a single delivery order transaction. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $46,054.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Taltz 80 mg/mL auto-injector (2-pack) pharmaceutical product. The contract, which is set to be completed by August 1, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This competitively awarded delivery order represents a continuation of AmerisourceBergen's ongoing role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of TALTZ 80 mg/ml auto-injector (2-pack) with a ceiling value of $9,029.13 under a firm fixed-price contract type. This award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999.9 million through December 2026. The contract was competitively awarded with no...
- The Defense Logistics Agency awarded a $4,083.21 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector (2-pack) on July 28, 2025, with completion targeted for July 29, 2025. This non-competitive delivery order utilizes firm fixed-price pricing and is fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The award represents a single-line pharmaceutical procurement supporting federal medical supply needs, likely for military or veteran healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication, valued at $72,800.96. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract carries an ultimate completion date of August 1, 2025, and performance will be executed from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a $14,482.79 delivery order to AmerisourceBergen Drug Corp for the supply of TALTZ 80 mg/mL autoinjector medication. This is a firm fixed-price, non-set-aside contract with a completion date of July 28, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency awarded a $11,664.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on July 31, 2025, with completion due August 1, 2025. This non-set-aside contract represents a small-value pharmaceutical supply delivery executed through AmerisourceBergen's existing federal contract vehicle with DLA. The award leverages the contractor's established relationship with the Defense Logistics Agency Medical Supply Chain, which has...
- The Defense Logistics Agency awarded a $19,479.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector (2-pack) pharmaceutical supplies on August 8, 2025, with an ultimate completion date of August 11, 2025. The contract is unclassified as a set-aside and represents a child award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The place of...
- The Defense Logistics Agency (DLA) awarded a $9,973.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of TALTZ 80 mg/mL auto-injector (2-pack) pharmaceutical product, with an ultimate completion date of July 30, 2025. This is a non-set-aside award issued on July 29, 2025, with fulfillment based at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Taltz 80 mg/ml auto-injector two-packs, with a firm fixed price ceiling value of $46,869.29. This non-set-aside competitive award is classified as a delivery order with an ultimate completion date of August 12, 2025, and represents a continuation of the vendor's extensive pharmaceutical supply relationship with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD9V7Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,228.37 on August 11, 2025, for the supply of TALTZ 80 MG/ML AutoInjector (2-pack). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 12, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract utilizes no set-aside provisions and represents a routine pharmaceutical procurement through established federal supply channels. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. The parent IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor, AmerisourceBergen holds a significant position within the DLA Medical Supply Chain and continues to compete for pharmaceutical procurement supporting federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.2k | 8/11/25 |